Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement

Annals of Internal Medicine

Volumn 146, Issue 5, 2007, Pages 361-364

  Calonge, Ned ^a,b   Petitti, Diana B ^a,c   DeWitt, Thomas G ^a,d   Gordis, Leon ^a,e   Gregory, Kimberly D ^a,f   Harris, Russell ^a,g   Kizer, Kenneth W ^a,h   LeFevre, Michael L ^a,i   Loveland Cherry, Carol ^a,j   Marion, Lucy N ^a,k   Moyer, Virginia A ^a,l   Ockene, Judith K ^a,m   Sawaya, George F ^a,n   Siu, Albert L ^a,o   Teutsch, Steven M ^a,p   Yawn, Barbara P ^a,q  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b Colorado Department of Public Health and Environment ^*  (United States)

^c KAISER PERMANENTE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h NATIONAL QUALITY FORUM   (United States)

ⁱ University of Missouri   (United States)

^j UNIVERSITY OF MICHIGAN SCHOOL OF NURSING   (United States)

^k MEDICAL COLLEGE OF GEORGIA   (United States)

^l UNIVERSITY OF TEXAS   (United States)

^m UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o MOUNT SINAI MEDICAL CENTER   (United States)

^p MERCK RESEARCH LABORATORIES   (United States)

^q Olmsted County Public Health Services   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

CANCER PREVENTION; CARDIOVASCULAR DISEASE; COLORECTAL CANCER; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY DISEASE; LANGUAGE; MEDICAL INFORMATION; METHODOLOGY; PHYSICIAN; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; STROKE; UNITED STATES; ADENOMA; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COLON POLYP; COLORECTAL TUMOR; COST OF ILLNESS; FEMALE; GASTROINTESTINAL DISEASE; INCIDENCE; MALE; MORTALITY; PRACTICE GUIDELINE;

ADENOMA; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLONIC POLYPS; COLORECTAL NEOPLASMS; COST OF ILLNESS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INCIDENCE; MALE; PRIMARY PREVENTION; UNITED STATES;

EID: 33947541519     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-146-5-200703060-00008     Document Type: Review

References (33)